Materialise A Two-Speed Story
Materialise enters 2026 with diverging momentum across its business segments:
- Medical continues to expand robustly, increasingly becoming the company's structural growth engine driven by deeper platform adoption and mass personalization.
- Software is transitioning successfully toward a subscription-based, cloud-native AM workflow platform, with significant medium-term operating leverage.
- Manufacturing faces persistent macro softness, particularly in European prototyping, with recovery dependent on mix shift toward aerospace and defence.
We updated our model ($ 8.0/€ 6.8 Target Price and ...